/Investor DB

CerraCap Ventures — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Predicta Medpredicta-med.cominFeb 2023

Predicta Med develops a data analytics platform using deep learning to identify at-risk autoimmune disease patients across multiple medical systems, enabling clinicians to intervene earlier and improve diagnostic outcomes.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Shlomit

Co-investorsICIICONYC labs

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Predicta

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.